Compounded drugs have not been reviewed or approved by the FDA for safety or effectiveness
Data extraction Data from the included trials were independently extracted by two reviewers
It also comes in oral formulations , which neither tirzepatide nor retatrutide currently offer in approved form, though oral tirzepatide is in development
Effect of liraglutide 3.0 mg treatment on weight reduction in obese antipsychotic-treated patients
The result for most patients is a meaningful reduction in appetite, slower digestion, and over time, significant weight loss
Who FuturHealth Is Best For FuturHealth may be a strong fit for those who: Are seeking a weight loss prescription without dealing with insurance hassles Prefer telehealth-based care and want to avoid in-person visits or lab work unless necessary Want clear pricing without hidden fees or variable coverage Have tried and failed with traditional weight loss methods Need a clinician-supported alternative to over-the-counter or unsafe options By offering both compounded semaglutide at $229/month and branded semaglutide options at $1,299/month, plus a flat-rate $129/month membership fee, FuturHealth is creating a scalable model for real-world users